The Boulder Valley's economic outlook may have taken a punch to the gut this month when biopharmaceutical giant Pfizer announced that it plans to shutter its research and development operations in Boulder by the middle of this year, eliminating an enterprise that at one point employed nearly 300 people at its Walnut Street facility.
Life-sciences leaders: Pfizer s exit means opportunity – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Arpeggio Biosciences raised $17 million in a Series A funding round led by Builders VC. The startup is focused on measuring the transcriptome which refers to the full range of mRNA molecules expressed by an organism to develop better therapeutics.